Seagen Inc.
ANTIBODIES TO INTEGRIN AVB6 AND USE OF SAME TO TREAT CANCER

Last updated:

Abstract:

The invention provides antibodies that specifically bind to integrin .alpha.v.beta.6. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting .alpha.v.beta.6.

Status:
Application
Type:

Utility

Filling date:

8 Jan 2021

Issue date:

4 Nov 2021